SCHEMBL9703948

SCHEMBL9703948

C=CCOc1nc2cc(Cl)c(Cl)cc2nc1C(N)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.37
GAA P10253 2/20 0.36
TSHR P16473 1/20 0.36
GLP1R P43220 1/20 0.36
HTR2A P28223 2/20 0.33
HTR2C P28335 2/20 0.33
HTR2B P41595 2/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
MGMT P16455 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CCNA1 P78396 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HIF1A Q16665 1/20 0.32
LMNA P02545 2/20 0.32
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIK1 P39086 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9703450 0.89 GAA (0.43) ATMGAATSHRGLP1RMEN1
SCHEMBL9705817 0.81 HIF1A (0.31) ATMGAAHIF1ANPC1RAB9A
SCHEMBL9704210 0.81 PGK1 (0.36) ATMGAATSHRGLP1RMEN1
SCHEMBL9703955 0.76 HRH4 (0.43) GAATSHRGLP1RLMNAGRIN2D
SCHEMBL9703518 0.71 GAA (0.47) ATMGAATSHRGLP1RHTR2A
SCHEMBL9703856 0.63 GRIN2D (0.49) GLP1RMEN1KMT2ALMNAGRIN2D
SCHEMBL31186096 0.62 SMN1; SMN2 (0.42) GAATSHRHIF1ALMNANPC1
SCHEMBL5821296 0.61 CA12 (0.42) GAATSHRMEN1KMT2ALMNA
SCHEMBL9703926 0.60 GRIN2D (0.74) GAATSHRMEN1KMT2ALMNA
SCHEMBL3614700 0.59 ALDH1A1 (0.38) TSHRCCNA2CDK2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992011245-A1 2-ACYLAMIDO DERIVATIVES OF 3,4-DIHYDRO-3-OXO-QUINOXALINE HAVING PHARMACEUTICAL ACTIVITY WARNER-LAMBERT COMPANY (US) 1992-07-09 WO disclosed